MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Lack of Toll-like receptor 4 is associated with accumulation of alpha-synuclein in the midbrain Parkinson’s disease mice.

    C. Conte, G. Mariucci, R. Cafaro (Perugia, Italy)

    Objective: In this study we aimed to investigate the potential role of Toll-like receptor 4 (TLR4) in mediating both the dopaminergic neuron loss and alpha-synuclein (alpha-SYN)…
  • 2022 International Congress

    Co-contractions as a Biomarker for DBS Efficacy in Dystonia

    S. Lagerweij, J. van Zijl, H. Eggink, M. Smit, M. van Egmond, J. Elting, J. van Dijk, D. Oterdoom, M. Tijssen (Groningen, Netherlands)

    Objective: Deep brain stimulation of the globus pallidus interna (GPi-DBS) is a treatment option for medication-refractory dystonia. However, the clinical outcome after DBS-GPi is variable,…
  • 2022 International Congress

    Remote identification of early, sensor-based markers of Parkinson’s Disease using participants’ smartphones: The Parkinson Progression Marker Initiative Digital sub-study

    W. Popp, K. Taylor, T. Perumal, C. Tanner, A. Siderowf, L. Chahine, E. Brown, T. Simuni, T. Foroud, T. Kustermann, G. Pagano, H. Svoboda, M. Lindemann, K. Marek (Basel, Switzerland)

    Objective: To summarize the design of the Parkinson’s Progression Markers Initiative (PPMI) Digital sub-study. The study objective is to identify the earliest signs and symptoms…
  • 2022 International Congress

    Non-myoclonic Subacute Sclerosing Pan Encephalitis in Adulthood

    S. Garg, K. Shetty (Bengaluru, India)

    Objective: We report a case of subacute sclerosing panencephalitis (SSPE) presenting after a long latency without the usual clinical clues that aid in diagnosis. Background:…
  • 2022 International Congress

    A systematic review of non-motor symptoms in atypical parkinsonian syndromes

    P. Ananthavarathan, B. Patel, R. Lamb, S. Peroos, N. Malek (London, United Kingdom)

    Objective: We wanted to systematically analyse the repertoire of NMS in patients with progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD) and…
  • 2022 International Congress

    Gait Characteristics from Daily Life Increase Ability to Predict Future Falls in People with Parkinson’s Disease

    V. Shah, J. Mcnames, G. Harker, P. Carlson-Kuhta, J. Nutt, M. El Gohary, K. Sowalsky,, M. Mancini, F. Horak (Portland, USA)

    Objective: We investigated if digital measures of different aspects of gait (walking and turning) from a week of daily activities increase discriminative ability to predict…
  • 2022 International Congress

    Profiling the biochemical lysosomal activities in blood of patients with LRRK2 G2019S associated Parkinson’s disease

    K. Basharova, A. Bezrukova, I. Miliukhina, A. Timofeeva, E. Zakharova, S. Pchelina, T. Usenko (Gatchina, Russian Federation)

    Objective: To replicate the previous study of Alcalay and coauthors on estimation of lysosomal enzymes activities [1] with additional estimation of corresponding substrates in patients…
  • 2022 International Congress

    A patient with childhood-onset hearing loss and adult-onset ataxia was genetically diagnosed with Perrault syndrome 5

    J. Park, J. Seok (Cheonan, Republic of Korea)

    Objective: A case of adult-onset ataxia with multiple neurologic deficits and ovarian dysgenesis was genetically diagnosed as Perrault syndrome 5 for the first time in…
  • 2022 International Congress

    COMPARISON OF CERVICAL, OCULAR AND MASSETER VESTIBULAR EVOKED MYOGENIC POTENTIALS IN PARKINSON PATIENTS ACCORDING TO CLINICAL SUBGROUPS

    G. Sahbaz, R. Inan, B. Barut (Istanbul, Turkey)

    Objective: The aim of this study is to reveal the differences in the effect of brainstem reflexes between the motor subtypes of PD, akinetic rigid(AR)…
  • 2022 International Congress

    SCFAs participate in the pathogenesis of Parkinson’s disease by regulating NLRP3 inflammasomes activation

    Z. Mao, J. Xiong, Z. Min, Z. Xue (Wuhan, China)

    Objective: To explore the role and related mechanism of gut microbiota metabolites short-chain fatty acids(SCFAs) in the pathogenesis of Parkinson's disease(PD). Background: Growing research have…
  • « Previous Page
  • 1
  • …
  • 773
  • 774
  • 775
  • 776
  • 777
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley